Annual Drug Patent Expirations for TEFLARO Teflaro is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Allergan drug TEFLARO appeared first…
Annual Drug Patent Expirations for CONZIP Conzip is a drug marketed by Cipher Pharms Inc and is included in one NDA. It is available from five suppliers. There is one…
The post New patent expiration for Cipher Pharms drug CONZIP appeared first on DrugP…
New patent expiration for Cipher Pharms drug CONZIP Read Post »
Annual Drug Patent Expirations for SPIRIVA Spiriva is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from two suppliers. There are sixteen patents…
The post New patent expiration for Boehringer Ingelheim drug SPIRI…
New patent expiration for Boehringer Ingelheim drug SPIRIVA Read Post »
Annual Drug Patent Expirations for LEXISCAN Lexiscan is a drug marketed by Astellas and is included in one NDA. It is available from two suppliers. There are three patents protecting…
The post New patent expiration for Astellas drug LEXISCAN appeared f…
New patent expiration for Astellas drug LEXISCAN Read Post »
Annual Drug Patent Expirations for ZOLADEX Zoladex is a drug marketed by Tersera and is included in two NDAs. It is available from two suppliers. There are two patents protecting…
The post New patent expiration for Tersera drug ZOLADEX appeared first o…
ORACEA (doxycycline) Galderma labs lp Patent: 9,241,946 Expiration: Apr 5, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug Paten…
Drug Patent Expirations for the Week of April 3, 2022 Read Post »
Annual Drug Patent Expirations for ORACEA Oracea is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from two suppliers. There are eleven…
The post New patent expiration for Galderma Labs drug ORACEA appeared first on Dru…
New patent expiration for Galderma Labs drug ORACEA Read Post »
Annual Drug Patent Expirations for NOXAFIL Noxafil is a drug marketed by Merck Sharp Dohme, Schering, and Msd Merck Co and, and is included in four NDAs. It is available…
The post New patent expiration for Schering drug NOXAFIL appeared first on DrugPa…
ARESTIN (minocycline hydrochloride) Orapharma Patent: 7,699,609 Expiration: Mar 29, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The pos…
Drug Patent Expirations for the Week of March 27, 2022 Read Post »
Annual Drug Patent Expirations for ARESTIN Arestin is a drug marketed by Orapharma and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent expiration for Orapharma drug ARESTIN appeared first…
New patent expiration for Orapharma drug ARESTIN Read Post »